ABOUT US > What's New
What's New
February
Bulk Manufacturer of Controlled Substances Registration (February 11, 2019)
Robert T. Perez, M.D.; Decision and Order (February 11, 2019)
Miles J. Nelson, M.D.; Decision and Order (February 11, 2019)
Paul Surinder Singh, D.O.; Decision And Order (February 11, 2019)
PerkinElmer, Inc. (February 11, 2019)
Stepan Company (February 11, 2019)
Almac Clinical Services Incorp (ACSI) (February 11, 2019)
Importer of Controlled Substances Registration (February 7, 2019)
Importer of Controlled Substances Registration (February 7, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)
IsoSciences, LLC (February 7, 2019)
Kinetochem, LLC (February 7, 2019)
Johnson Matthey Pharmaceutical Materials, Inc. (February 7, 2019)
Research Triangle Institute (February 7, 2019)
Microgenics Corporation Thermo Fisher Scientific (February 7, 2019)
Chattem Chemicals (February 7, 2019)
Kurt L. Pflieger, M.D.; Order Dismissing Order To Show Cause (February 7, 2019)
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as Schedule II Controlled Substances; Correction (February 7, 2019)
January 2019
Placement of MAB-CHMINACA in Schedule I (January 29, 2019)
December 2018
Notice of Intent: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I (December 28, 2018)
Importer of Controlled Substances Registration (December 27, 2018)
Importer of Controlled Substances Registration (December 27, 2018)
Stephen R. Kovacs, D.O.; Decision and Order (December 27, 2018)
Johnson Matthey Inc. (December 27, 2018)
Myoderm (December 27, 2018)
Agilent Technologies (December 27, 2018)
Usona Institute (December 14, 2018)
Arizona Department of Corrections (December 14, 2018)
Usona Institute (December 14, 2018)
Eli-Elsohly Laboratories (December 13, 2018)
Cambrex High Point, Inc. (December 13, 2018)
Siegfried USA, LLC (December 13, 2018)
Mylan Pharmaceuticals Inc. (December 13, 2018)
Noramco Inc. (December 13, 2018)
Mylan Technologies, Inc. (December 13, 2018)
Bulk Manufacturer of Controlled Substances Registration (December 6, 2018)
Decision and Order: Zelideh I. Cordova-Velazco, M.D. (December 6, 2018)
Exempt Chemical Preparations Under the Controlled Substances Act (December 3, 2018)
November
Steve Fanto, M.D.; Decision and Order (November 30, 2018)
Narciso A. Reyes, M.D.; Decision and Order (November 30, 2018)
Final Order: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I (November 29, 2018)
Importer of Controlled Substances Registration (November 27, 2018)
Bulk Manufacturer of Controlled Substances Registration (November 27, 2018)
Importer of Controlled Substances Registration (November 27, 2018)
Noramco Inc. (November 27, 2018)
Insys Manufacturing, LLC (November 27, 2018)
Cayman Chemical Company (November 27, 2018)
Akorn, Inc. (November 27, 2018)
Cambridge Isotope Laboratories (November 27, 2018)
GE Healthcare (November 27, 2018)
Fisher Clinical Services, Inc. (November 27, 2018)
Sigma Aldrich Co., LLC (November 27, 2018)
Organix, Inc. (November 20, 2018)
Patheon API Manufacturing, Inc. (November 20, 2018)
Edward A. Ridgill, M.D.; Decision and Order (November 20, 2018)
Eldor Brish, M.D.; Decision and Order (November 20, 2018)
Lipomed (November 20, 2018)
Janssen Pharmaceuticals Inc. (November 20, 2018)
Bulk Manufacturer of Controlled Substances Registration (November 9, 2018)
Chattem Chemicals (November 9, 2018)
Bulk Manufacturer of Controlled Substances Registration (November 2, 2018)
Janssen Pharmaceuticals, Inc. (November 2, 2018)
October
Importer of Controlled Substances Registration (October 30, 2018)
Bulk Manufacturer of Controlled Substances Registration (October 30, 2018)
Insys Manufacturing, LLC (October 30, 2018)
Sigma Aldrich Research (October 30, 2018)
Eric Lee Knight, M.D.; Decision and Order (October 30, 2018)
Cambrex High Point, Inc. (October 30, 2018)
United States Pharmacopeial Convention (October 30, 2018)
Sharp (Bethlehem), LLC (October 30, 2018)
Fisher Clinical Services, Inc. (October 30, 2018)
Catalent CTS, LLC (October 30, 2018)
Hisham M. Shawish, M.D.; Decision and Order (October 25, 2018)
Bulk Manufacturer of Controlled Substances Registration (October 19, 2018)
Importer of Controlled Substances Registration (October 19, 2018)
Noramco Inc. (October 19, 2018)
Fisher Clinical Services, Inc. (October 19, 2018)
Importer of Controlled Substances Registration (October 15, 2018)
Specgx, LLC (October 15, 2018)
Phillip O. Rawlings, Jr., M.D.; Decision and Order (October 15, 2018)
Cambrex High Point, Inc. (October 15, 2018)
Bulk Manufacturer of Controlled Substances Registration (October 2, 2018)
Importer of Controlled Substances Registration (October 2, 2018)
Importer of Controlled Substances Registration (October 2, 2018)
Rhodes Technologies (Correction) (October 2, 2018)
AMPAC Fine Chemicals, LLC (October 2, 2018)
Cambrex Charles City (October 2, 2018)
R & D Systems, Inc. (October 2, 2018)
September
Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements (September 28, 2018)
Nanosyn, Inc. (September 27, 2018)
Absolute Standards, Inc. (September 27, 2018)
Halo Pharmaceutical, Inc. (September 24, 2018)
AMPAC Fine Chemicals Virginia, LLC (September 24, 2018)
Sharon C. Worosilo, M.D., Decision and Order (September 19, 2018)
Brian Thomas Nichol, M.D., Decision and Order (September 19, 2018)
Alcami Carolinas Corporation (September 14, 2018)
Bulk Manufacturer of Controlled Substances Registration (September 7, 2018)
